Ascendis Pharma A/S
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| A1SN34.SA | 1672.HK | BBIO | RARE | PTGX | ARWR | |
|---|---|---|---|---|---|---|
| Market cap | 5.80B | 5.13B | 14.88B | 1.64B | 8.94B | 8.24B |
| P/E (TTM) | 1.3 | — | — | — | 134.2 | — |
| Forward P/E | — | -17.5 | -220.6 | 71.2 | -1,392.6 | -11.7 |
| Price/book | 0.7 | 1.9 | -5.7 | -5.4 | 10.6 | 17.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +25.91% | −52.10% | +24.17% | −44.56% | +79.71% | +55.68% |
| Today | 0.00% | +7.23% | −1.94% | −6.44% | −3.59% | −5.37% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All A1SN34.SA news ›Ascendis Pharma A/S $ASND Stock: Sterling Capital Management LLC Reduces Position
Posted by Kim Johansen on Oct 26th, 2026 Read Our Latest Stock Analysis on Ascendis Pharma A/S Ascendis Pharma A/S is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases. The company uses its…
Head-To-Head Survey: Avalo Therapeutics (NASDAQ:AVTX) & Ascendis Pharma A/S (NASDAQ:ASND)
Posted by Kim Johansen on Oct 22nd, 2026 Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) and Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two…
Financial Comparison: Generate Biomedicines (NASDAQ:GENB) versus Ascendis Pharma A/S (NASDAQ:ASND)
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) and Generate Biomedicines (NASDAQ:GENB – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
- defenseworld.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.